Why Rs 150 for you, Rs 300-400 for states?: Supreme Court asks Centre on vaccine pricing

0
35


New Delhi: The Supreme Court on Friday (April 30) posed a string of questions in entrance of the central authorities relating to vaccine pricing and distribution.

A bench comprising Justice DY Chandrachud, LN Rao and SR Bhat requested the Centre to not let the non-public producers dictate the pricing and distribution of vaccines and take the duty to take action itself.

“Do not leave the vaccine pricing and distribution to the manufactures, This is equity over public goods. You need to pick up the responsibility for this,” the court docket was quoted as saying by Live Law.

Justice Chandrachud requested why ought to the vaccine producers get to determine which states get what number of vaccine doses.

“Can this question of equity be left to the private sector?” he requested.

Justice Bhat stated that for the reason that authorities has spent on the event of vaccines it ought to have a say within the matter.

“Rs 4500 crores were funded to the organisation for the development of the vaccine. Then we also own the product!” stated Bhat.

Calling the pricing problem is awfully critical, the choose went on to ask why there’s a distinction in value of vaccines for the states and the central authorities.

“The same manufacturer is saying Rs 150 to you and 300-400 to the states! At a bulk level, the price difference will be of Rs 30,000 to 40,000 crores. Why must the nation pay this?” he stated.

“Why can’t the central authorities get it in bulk after which have the states it picked up?” continued the choose.

Justice Bhat additional cited the costs of vaccines within the United States and the European Union which can be a lot decrease in comparison with that in India.

“It is $2.15 in the US and it is low even in the EU. Why must it be Rs 600 to the states and Rs 1200 to the private hospitals in India? Our drug consumption parallels no one! We are the largest consumer,” stated Justice Bhat.

Live TV





Source hyperlink